Pfizer UK

Last updated

Pfizer Ltd
Company typeSubsidiary
Industry Pharmaceutical
Founded1952
Headquarters
Tadworth, Surrey
,
United Kingdom
Products Pharmaceuticals
Number of employees
2,500
Parent Pfizer
Website www.pfizer.co.uk

Pfizer UK (officially Pfizer Ltd) is the principal subsidiary of the multinational pharmaceutical company Pfizer in the United Kingdom. [1]

Contents

Pfizer UK has its business headquarters in Tadworth, Surrey, major offices in Maidenhead, Berkshire, research and development facilities in Cambridge, Cambridgeshire and Sandwich, Kent, and a manufacturing and distribution site in Havant, Hampshire. [2]

History

1952–2000

To satisfy regulations then in place in the United Kingdom on the importation of medicines, Pfizer established a compounding operation in Folkestone, Kent, in the Autumn of 1952. [3] Pfizer acquired an 80-acre site on the outskirts of Sandwich in 1954 to enable the expansion of its Kent-based activities. [3] In 1955, Pfizer established an animal-feed plant at the Sandwich site and entered the UK non-prescription market for the first time. [4] An Agricultural Division was opened at the Sandwich site in 1957, and in 1964, Pfizer acquired land adjacent to its existing site in Sandwich, known as the 'West Site'. [4] Pfizer UK established 'Pfizer Central Research' in 1971 with the mission to discover new pharmaceutical, chemical and agricultural products for Pfizer's worldwide operations. [5]

Pfizer UK was presented with the Queen's Award for Technological Achievement in 1979, in recognition of the outstanding contribution made to tropical medicine by the medicine Mansil (oxamniquine), which had been developed at the Sandwich site. [5] Feldene (piroxicam), a non-steroidal anti-inflammatory drug developed jointly by the Sandwich site and Pfizer's R&D facility in Groton, United States, was launched in 1980. [5] In 1984, a third phase of buildings was completed at the Sandwich site. [5] The oral antifungal drug Diflucan (fluconazole), which had been discovered at the Sandwich site, was launched in 1988. [5] In December 1997, Pfizer announced an investment of £109 million in a new research facility at the Sandwich site, creating 1,000 jobs. [6]

2000–2010

In April 2001, Pfizer UK received the Queen's Award for Enterprise for the discovery and development of the erectile dysfunction drug Viagra (sildenafil). [7] In 2002, Pfizer UK relocated its headquarters and sales and marketing functions to new offices at Walton Oaks, near Tadworth, Surrey. [7] In June 2003, Pfizer UK began offering employees at the Sandwich site the option of leaving work at noon on Fridays if their work was completed. [8] In September 2007, it was announced that Pfizer UK would close its manufacturing plant at Sandwich, with the loss of around 400 jobs. [9] Dr Ken Richardson was inducted into the US National Inventors Hall of Fame in May 2008 for his role in the discovery of Diflucan whilst working at Pfizer UK. [10] Construction of an £87 million link-road between the Sandwich site and the A299 was approved by HM Government in August 2009. [11]

2010–present

On 1 February 2011, Pfizer announced it would be closing the entire research and development facility at Sandwich within 18–24 months, as part of a company-wide plan to exit certain therapeutic areas including allergy and respiratory research, which was based at Sandwich. [12] [13] [14] In its announcement, Pfizer stated that most of the 2,400 workers at the site would be made redundant, although it hoped to transfer several hundred positions to other sites or to Pfizer partner companies. [15] On 4 February 2011, it was announced that the Science and Technology Select Committee would be requesting oral evidence from representatives of Pfizer and the Minister of State for Universities and Science, David Willetts, on the closure of the Sandwich site. [16]

In April 2011, Pfizer established Neusentis in Cambridge, intended to operate as a biotech-like unit combining research in pain, sensory disorders, and regenerative medicine. [17] Neusentis acquired biopharmaceutical company Icagen in November 2011. [17]

In June 2011, Pfizer renamed the Sandwich site 'Discovery Park' and put it on the market for sale. [18] In the same month, Pfizer announced it would retain 350 jobs at Discovery Park, [19] subsequently increased to 650 in November 2011. [20] In August 2011, it was announced that the Pfizer site at Sandwich would become an enterprise zone with discounted business rates, easier planning rules, and access to superfast broadband. [21] Pfizer sold the freehold to the Discovery Park site to Discovery Park Ltd, a private consortium, in August 2012. [22] As part of the sale, Pfizer agreed to take a lease of around 250,000 sq ft of offices and laboratories at the site. [22]

In August 2016, Pfizer acquired a portfolio of anti-infective medicines from AstraZeneca. [23]

In November 2023, Pfizer announced plans to eliminate 500 jobs at its Sandwich, Kent facility as part of a broader $3.5 billion cost-reduction strategy. This move follows the company's lowered annual revenue projections, affected by diminishing demand for its COVID-19 vaccine and treatment, which led to Pfizer's first quarterly loss since 2019. [24]

Operations

Discovery Park, Sandwich

Around 650 Pfizer employees are based at Discovery Park in Sandwich. [20] Pfizer operations at Discovery Park are focused on the delivery of the company's mid- to late-stage portfolio. [17] Activities at the site include Pharmaceutical Sciences; Medical Regulatory; Business Units; Quality Assurance; and Business Support Functions (Procurement & Operation, HR, Finance, Patents). [17] There is also a pilot plant production and solid and liquid dose manufacturing facility at the site. [17]

Neusentis, Cambridge

Neusentis was a biotech-like unit based in Cambridge which was focused on research in pain, sensory disorders, regenerative medicine, and auditory and visual disorders linked to ion channels. [17] Neusentis was responsible for Pfizer's first stem cell clinical study, initiated in 2011 for patients with AMD. [25] [17] Pfizer announced in December 2015 that it had decided to close the Neusentis unit with the loss of around 120 jobs. [26] However, the Devices Centre of Excellence (DCoE) remained in operation. [27]

Awards

In 1991, Pfizer UK was presented with the Queen's Award for Technological Achievement in recognition of its discovery of Diflucan. [7] In 1993, Pfizer UK was awarded the Queen's Award for Export Achievement. [7] In 1997 and 2000, Pfizer UK was awarded the Queen's Award for International Trade. [7]

See also

Related Research Articles

<span class="mw-page-title-main">Sildenafil</span> Drug for erectile dysfunction and hypertension

Sildenafil, sold under the brand name Viagra, among others, is a medication used to treat erectile dysfunction and pulmonary arterial hypertension. It is also sometimes used off-label for the treatment of certain symptoms in secondary Raynaud's phenomenon. It is unclear if it is effective for treating sexual dysfunction in females. It can be taken orally, intravenously, or through the sublingual route. Onset when taken orally is typically within twenty minutes and lasts for about two hours.

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

<span class="mw-page-title-main">Sandwich, Kent</span> Town in Kent, England

Sandwich is a town and civil parish in the Dover District of Kent, south-east England. It lies on the River Stour and has a population of 4,985. Sandwich was one of the Cinque Ports and still has many original medieval buildings, including several listed public houses and gates in the old town walls, churches, almshouses and the White Mill. While once a major port, it is now 2 miles (3 km) from the sea due to the disappearance of the Wantsum Channel. Its historic centre has been preserved. Sandwich Bay is home to nature reserves and two world-class golf courses, Royal St George's and Prince's. The town is also home to many educational and cultural events. Sandwich also gave its name to the food by way of John Montagu, 4th Earl of Sandwich, and the word sandwich is now found in several languages.

<span class="mw-page-title-main">GSK plc</span> UK healthcare company

GSK plc is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

<span class="mw-page-title-main">AstraZeneca</span> British pharmaceutical company

AstraZeneca plc (AZ) is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry is an industry involved in medicine that discovers, develops, produces, and markets pharmaceutical goods for use as drugs that function by being administered to patients using such medications with the goal of curing and/or preventing disease. Pharmaceutical companies may deal in "generic" medications and medical devices without the involvement of intellectual property, in "brand" materials specifically tied to a given company's history, or in both within different contexts. The industry's various subdivisions are all subject to a variety of laws and regulations that govern entire financial processes including the patenting, efficacy testing, safety evaluation, and marketing of these drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020, in total, and this showed a compound annual growth rate (CAGR) of 1.8% given the results of recent events.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

<span class="mw-page-title-main">Eisai (company)</span> Japanese pharmaceutical company

Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Astellas Pharma</span> Japanese pharmaceutical company

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd..

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

<span class="mw-page-title-main">Santaris Pharma</span> Biopharmaceutical company founded in Denmark

Santaris Pharma A/S was a biopharmaceutical company founded in 2003 in Copenhagen, Denmark. The company also had a branch in San Diego, California that opened in 2009. Created by a merger between Cureon and Pantheco, Santaris developed RNA-targeted medicines using a Locked Nucleic Acid (LNA) Drug Platform and Drug Development Engine.

<span class="mw-page-title-main">Wyeth</span> American pharmaceutical company

Wyeth was a pharmaceutical company until it was purchased by Pfizer in 2009. The company was founded in Philadelphia, Pennsylvania, in 1860 as John Wyeth and Brother. Its headquarters moved to Collegeville, Pennsylvania, and Madison, New Jersey, before its headquarters were consolidated with Pfizer's in New York City after the 2009 merger.

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.

Curia is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, Curia operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. Curia has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Company, Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

<span class="mw-page-title-main">Scientist.com (company)</span> Network of e-commerce marketplaces

Scientist.com is a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. The company was founded in 2007 by Kevin Lustig, Chris Petersen and Andrew Martin and launched its first public research marketplace in September 2008.

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.

Michael Yeadon is a British anti-vaccine activist and retired pharmacologist who attracted media attention in 2020 and 2021 for making false or unfounded claims about the COVID-19 pandemic and the safety of COVID-19 vaccines. The Times has described him as "a hero of Covid conspiracy theorists" and "a key figure in the antivax movement". Until 2011, he served as the chief scientist and vice-president of the allergy and respiratory research division of the drug company Pfizer, and is the co-founder and former CEO of the biotechnology company Ziarco.

References

  1. ↑ "Pfizer UK". The Times. 24 May 2009. Retrieved 25 November 2010.
  2. ↑ "Corporate overview". Pfizer. Retrieved 12 August 2012.
  3. 1 2 "Pfizer's history 1949–55". Pfizer UK. Archived from the original on 8 December 2010. Retrieved 25 November 2010.
  4. 1 2 "Pfizer's history 1955–70". Pfizer UK. Archived from the original on 8 December 2010. Retrieved 25 November 2010.
  5. 1 2 3 4 5 "Pfizer's history 1970–90". Pfizer UK. Archived from the original on 8 December 2010. Retrieved 25 November 2010.
  6. ↑ "Pfizer creates 1,000 jobs but Siemens thinks again in Tyneside" . The Independent. 12 December 1997. Archived from the original on 26 May 2022. Retrieved 14 August 2012.
  7. 1 2 3 4 5 "Pfizer's history 1990–2008". Pfizer UK. Archived from the original on 8 December 2010. Retrieved 25 November 2010.
  8. ↑ "Early finish for Friday workers". BBC News. 26 May 2003. Retrieved 25 November 2010.
  9. ↑ "Pfizer to shed more than 400 jobs". BBC News. 11 September 2007. Retrieved 14 August 2012.
  10. ↑ "Scientist joins US hall of fame". BBC News. 13 May 2008. Retrieved 25 November 2010.
  11. ↑ "Traffic-busting £87m link road gets green light". Kent Online. 25 August 2009. Retrieved 25 November 2010.
  12. ↑ "Pfizer to Close U.K. Center". The Wall Street Journal. 1 February 2011. Retrieved 1 February 2011.
  13. ↑ "Drug giant Pfizer to pull out of Kent". Kent Online. 1 February 2011. Archived from the original on 10 June 2012. Retrieved 1 February 2011.
  14. ↑ "Pfizer to shut major Sandwich site, home of Viagra". Reuters. 1 February 2011. Archived from the original on 2 March 2020. Retrieved 1 February 2011.
  15. ↑ "Pfizer to close UK research site". BBC News. 1 February 2011. Retrieved 1 February 2011.
  16. ↑ "MPs to grill Pfizer on closure of Sandwich site". Reuters. 4 February 2011. Archived from the original on 22 December 2015. Retrieved 4 February 2011.
  17. 1 2 3 4 5 6 7 "R&D Locations: England, UK". Pfizer. Retrieved 12 August 2012.
  18. ↑ "Pfizer site in Sandwich on market as 'Discovery Park'". BBC News. 13 June 2011. Retrieved 12 August 2012.
  19. ↑ "Pfizer to retain 350 staff at Sandwich". BBC News. 23 June 2011. Retrieved 12 August 2012.
  20. 1 2 "Pfizer site in Sandwich set to retain 650 jobs". BBC News. 4 November 2011. Retrieved 12 August 2012.
  21. ↑ "Kent business zone 'brings resilience' as Pfizer shuts". BBC News. 17 August 2011. Retrieved 12 August 2012.
  22. 1 2 "Sandwich Pfizer site sold to private consortium". BBC News. 2 August 2012. Retrieved 12 August 2012.
  23. ↑ NathanBomey. "Pfizer acquires anti-infection drugs from AstraZeneca". USA TODAY. Retrieved 26 March 2019.
  24. ↑ "Pfizer to cut 500 jobs at UK site as part of wider cost cuts". Reuters. 14 November 2023. Retrieved 14 November 2023.
  25. ↑ "Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies". Pfizer. 23 April 2009. Retrieved 22 December 2022.
  26. ↑ "Pfizer is shuttering another U.K. R&D outpost, ditching 120 jobs". Fierce Biotech. 3 December 2015. Retrieved 31 July 2016.
  27. ↑ "UK site a casualty as Pfizer reduces pain R&D". www.pmlive.com. 8 December 2015. Retrieved 26 March 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.